Skip to main page content
Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

My NCBI Filters
Results by year

Table representation of search results timeline featuring number of search results per year.

Year Number of Results
1974 1
1975 1
1976 1
1977 3
1978 6
1983 1
1984 1
1985 4
1986 6
1987 10
1988 15
1989 6
1990 8
1991 6
1992 2
1993 5
1994 8
1995 12
1996 12
1997 8
1998 7
1999 6
2000 7
2001 7
2002 8
2003 5
2004 3
2005 5
2006 8
2007 9
2008 8
2009 7
2010 4
2011 7
2012 7
2013 5
2014 6
2015 5
2016 6
2017 5
2018 9
2019 9
2020 3
2021 6
Text availability
Article attribute
Article type
Publication date

Search Results

249 results
Results by year
Filters applied: . Clear all
Page 1
Pevonedistat, a first-in-class NEDD8-activating enzyme inhibitor, combined with azacitidine in patients with AML.
Swords RT, Coutre S, Maris MB, Zeidner JF, Foran JM, Cruz J, Erba HP, Berdeja JG, Tam W, Vardhanabhuti S, Pawlikowska-Dobler I, Faessel HM, Dash AB, Sedarati F, Dezube BJ, Faller DV, Savona MR. Swords RT, et al. Among authors: faller dv. Blood. 2018 Mar 29;131(13):1415-1424. doi: 10.1182/blood-2017-09-805895. Epub 2018 Jan 18. Blood. 2018. PMID: 29348128 Free PMC article. Clinical Trial.
Randomized phase 2 trial of pevonedistat plus azacitidine versus azacitidine for higher-risk MDS/CMML or low-blast AML.
Sekeres MA, Watts J, Radinoff A, Sangerman MA, Cerrano M, Lopez PF, Zeidner JF, Campelo MD, Graux C, Liesveld J, Selleslag D, Tzvetkov N, Fram RJ, Zhao D, Bell J, Friedlander S, Faller DV, Adès L. Sekeres MA, et al. Among authors: faller dv. Leukemia. 2021 Jul;35(7):2119-2124. doi: 10.1038/s41375-021-01125-4. Epub 2021 Jan 22. Leukemia. 2021. PMID: 33483617 Free PMC article. No abstract available.
Klotho Pathways, Myelination Disorders, Neurodegenerative Diseases, and Epigenetic Drugs.
Moos WH, Faller DV, Glavas IP, Harpp DN, Kanara I, Mavrakis AN, Pernokas J, Pernokas M, Pinkert CA, Powers WR, Sampani K, Steliou K, Vavvas DG, Zamboni RJ, Kodukula K, Chen X. Moos WH, et al. Among authors: faller dv. Biores Open Access. 2020 Mar 31;9(1):94-105. doi: 10.1089/biores.2020.0004. eCollection 2020. Biores Open Access. 2020. PMID: 32257625 Free PMC article. Review.
Targeting the RAS oncogene.
Takashima A, Faller DV. Takashima A, et al. Among authors: faller dv. Expert Opin Ther Targets. 2013 May;17(5):507-31. doi: 10.1517/14728222.2013.764990. Epub 2013 Jan 30. Expert Opin Ther Targets. 2013. PMID: 23360111 Free PMC article. Review.
Epigenetic Treatment of Persistent Viral Infections.
Moos WH, Pinkert CA, Irwin MH, Faller DV, Kodukula K, Glavas IP, Steliou K. Moos WH, et al. Among authors: faller dv. Drug Dev Res. 2017 Feb;78(1):24-36. doi: 10.1002/ddr.21366. Epub 2016 Oct 20. Drug Dev Res. 2017. PMID: 27761936 Review.
Microbiota and Neurological Disorders: A Gut Feeling.
Moos WH, Faller DV, Harpp DN, Kanara I, Pernokas J, Powers WR, Steliou K. Moos WH, et al. Among authors: faller dv. Biores Open Access. 2016 May 1;5(1):137-45. doi: 10.1089/biores.2016.0010. eCollection 2016. Biores Open Access. 2016. PMID: 27274912 Free PMC article. Review.
Gut Microbiota and Salivary Diagnostics: The Mouth Is Salivating to Tell Us Something.
Kodukula K, Faller DV, Harpp DN, Kanara I, Pernokas J, Pernokas M, Powers WR, Soukos NS, Steliou K, Moos WH. Kodukula K, et al. Among authors: faller dv. Biores Open Access. 2017 Oct 1;6(1):123-132. doi: 10.1089/biores.2017.0020. eCollection 2017. Biores Open Access. 2017. PMID: 29098118 Free PMC article. Review.
249 results
You have reached the last page of results. A maximum of 10,000 results are available.
Jump to page